Kymera
degrader clinical development plan in liquid and solid tumors | Kymera
Company
Deck Type
IPO
Sector
Industry
Deck date
August 2020
Slide
45 of 49
Similar slides by Kymera
See diffirences between slides (animation)
IPO
August 2020
development in mutant | Kymera
Related slides by other companies
Vincera
SPAC
September 2020
clinical development plan | Vincera
Compass Therapeutics
Investor Presentation
May 2023
clinical development plans | Compass Therapeutics
Compass Therapeutics
Investor Presentation
February 2023
clinical development plans | Compass Therapeutics
Aeglea BioTherapeutics
Investor Presentation
August 2020
novel human enzyme in clinical development to treat due to beta deficiency | Aeglea BioTherapeutics
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights